Covered recipient · General Payments record
VIRGINIA MACHADO KINSELLA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$12,934.15
- Reported across 287 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,851.14 | 70 |
| Education | $85.35 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SOBI, INC | $184.21 | 4 |
| Janssen Biotech, Inc. | $171.97 | 9 |
| Merck Sharp & Dohme Corporation | $154.81 | 8 |
| ABBVIE INC. | $148.61 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $143.13 | 8 |
| Kite Pharma, Inc. | $121.36 | 1 |
| GlaxoSmithKline, LLC. | $107.30 | 3 |
| Sirtex Medical Inc | $105.34 | 1 |
| Daiichi Sankyo Inc. | $97.11 | 4 |
| Stemline Therapeutics Inc. | $95.16 | 1 |
| Acerta Pharma LLC | $73.76 | 3 |
| E.R. Squibb & Sons, L.L.C. | $58.38 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.81 | 2 |
| Incyte Corporation | $43.62 | 2 |
| PFIZER INC. | $41.53 | 2 |
| Gilead Sciences, Inc. | $35.83 | 2 |
| EISAI INC. | $34.84 | 2 |
| Genmab U.S., Inc. | $32.42 | 1 |
| AVEO Pharmaceuticals, Inc. | $30.05 | 1 |
| BeiGene USA, Inc. | $27.91 | 1 |
| Apellis Pharmaceuticals, Inc. | $25.58 | 1 |
| SERVIER PHARMACEUTICALS LLC | $24.06 | 1 |
| Pharmacosmos Therapeutics Inc. | $22.23 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $21.42 | 1 |
| Iovance Biotherapeutics, Inc. | $20.02 | 1 |
| Blueprint Medicines Corporation | $18.82 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $17.68 | 1 |
| EMD Serono, Inc. | $17.03 | 1 |
| GENZYME CORPORATION | $16.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (72)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.